Susquehanna International Group, LLP Celldex Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $104,895 - $145,800	-4,500 Reduced 4.17%	103,500 $2.62 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $2.13 Million - $2.95 Million	66,300 Added 158.99%	108,000 $3.67 Million
Q2 2024 Aug 15, 2024	SELL	$32.76 - $42.56 $334,152 - $434,112	-10,200 Reduced 19.65%	41,700 $1.54 Million
Q1 2024 May 07, 2024	SELL	$35.22 - $51.88 $3.02 Million - $4.45 Million	-85,800 Reduced 62.31%	51,900 $2.18 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $1.14 Million - $2.04 Million	-50,300 Reduced 26.76%	137,700 $5.46 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $2.61 Million - $3.84 Million	102,600 Added 120.14%	188,000 $5.17 Million
Q2 2023 Aug 11, 2023	SELL	$30.29 - $38.28 $5.49 Million - $6.94 Million	-181,300 Reduced 67.98%	85,400 $2.9 Million
Q1 2023 May 16, 2023	BUY	$34.78 - $47.43 $4.91 Million - $6.7 Million	141,200 Added 112.51%	266,700 $9.6 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $716,724 - $1.17 Million	25,800 Added 25.88%	125,500 $5.59 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $6.54 Million - $10.8 Million	-288,100 Reduced 74.29%	99,700 $2.8 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $3.87 Million - $7.05 Million	188,900 Added 94.97%	387,800 $10.5 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $4.95 Million - $7.04 Million	-179,000 Reduced 47.37%	198,900 $6.78 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $495,952 - $782,153	13,900 Added 3.82%	377,900 $14.6 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $2.8 Million - $5.41 Million	96,600 Added 36.13%	364,000 $19.7 Million
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $2.47 Million - $4.23 Million	119,500 Added 80.8%	267,400 $8.94 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $2.23 Million - $4.12 Million	137,700 Added 1350.0%	147,900 $3.05 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $3.4 Million - $5.16 Million	-227,000 Reduced 95.7%	10,200 $179,000
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $1.03 Million - $1.62 Million	-106,500 Reduced 30.99%	237,200 $3.52 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $534,198 - $4.45 Million	331,800 Added 2788.24%	343,700 $4.47 Million
Q1 2020 May 15, 2020	BUY	$1.55 - $3.07 $2,015 - $3,991	1,300 Added 12.26%	11,900 $20,000
Q4 2019 Feb 14, 2020	SELL	$2.11 - $2.8 $1,266 - $1,680	-600 Reduced 5.36%	10,600 $24,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.75 $38,745 - $51,975	-18,900 Reduced 62.79%	11,200 $24,000
Q2 2019 Aug 14, 2019	BUY	$2.43 - $5.09 $6,561 - $13,743	2,700 Added 9.85%	30,100 $81,000
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $94,530 - $283,590	27,400 New	27,400 $135,000

Others Institutions Holding CLDX

# of Institutions

196

Shares Held

60.7M

Call Options Held

960K

Put Options Held

675K

Kynam Capital Management, LP Princeton, NJ

5.06M
Shares

$99.1 Million
8.11% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$91.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.88M
Shares

$76 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

3.75M
Shares

$73.5 Million
1.82% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.56M
Shares

$69.6 Million
0.01% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $915M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account